Shandong Weigao Orthopaedic Device Co., Ltd (SHA:688161)
22.07
+0.70 (3.28%)
At close: Oct 23, 2026
SHA:688161 Revenue
Shandong Weigao Orthopaedic Device had revenue of 408.09M CNY in the quarter ending June 30, 2026, a decrease of -9.46%. This brings the company's total for the last twelve months to 1.49B, up 2.99% year-over-year. In the year 2025, Shandong Weigao Orthopaedic Device had annual revenue of 1.52B with 4.82% growth. That makes Shandong Weigao Orthopaedic Device the 16,667th largest company in the world by revenue and 3,009th in China.
Revenue (ttm)
1.49B
Revenue Growth
+2.99%
P/S Ratio
5.90
Revenue / Employee
736.89K
Employees
2,017
Market Cap
8.77B
Revenue by Geography
- China 1.43B 94.3%
- Overseas 86.36M 5.7%
Fiscal year ended Dec 31, 2025 See the full SHA:688161 breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.52B | 70.08M | 4.82% |
| Dec 31, 2024 | 1.45B | 169.17M | 13.18% |
| Dec 31, 2023 | 1.28B | -774.42M | -37.63% |
| Dec 31, 2022 | 2.06B | -95.57M | -4.44% |
| Dec 31, 2021 | 2.15B | 329.77M | 18.08% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Shinva Medical Instrument | 10.11B |
| Sinocare | 5.05B |
| Qingdao Haier Biomedical Co.,Ltd | 2.53B |
| SonoScape Medical | 2.40B |
| INKON Life Technology | 2.06B |
| Guangzhou Wondfo Biotech Co.,Ltd | 1.88B |
| Shanghai MicroPort Endovascular MedTech | 1.43B |
| Beijing Wandong Medical Technology | 1.38B |